The Melanoma Handbook
Stephan Ariyan, Harriet M. Kluger(Yale Cancer Center), Charlotte E. Ariyan(Memorial Sloan Kettering Cancer Center), Roy H. Decker(Yale University), Rossitza Lazova, Sarah A. Weiss, Jack M. Qian(South Shore Hospital), Deepak Narayan(American Society of Plastic Surgeons), Jocelyn Depathy, Anjela Galan, Dale Han, Skyler B. Johnson(University of Michigan), Mariam Totonchy(National Institutes of Health), Jonathan S. Leventhal(Yale University), Frank F. Kanthak, Swathi B. Reddy, Nour Kibbi(Yale University), Veronica Chiang(Yale University), Daniel C. Thomas, Sarah Persing, Veronica Shi, Samuel Kim, Danielle M. Bello, Mario Sznol
Cited by 2
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k